Related Experiment Videos
Biological properties of recombinant and of natural pro-urokinase
Thrombosis and Haemostasis
|August 30, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.
Journal of thrombosis and thrombolysis·2017
C1-inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis.
Journal of thrombosis and haemostasis : JTH·2007
Chromosomal translocation engineering to recapitulate primary events of human cancer.
Cold Spring Harbor symposia on quantitative biology·2006
Thrombolysis vs. bleeding from hemostatic sites by a prourokinase mutant compared with tissue plasminogen activator.
Journal of thrombosis and haemostasis : JTH·2006
Machine Learning Models for Suspected Pulmonary Embolism in Emergency Department Patients: A Multicentre Diagnostic Study.
Thrombosis and haemostasis·2026
A versatile Bacillus esterase reveals a carboxylesterase blueprint for PET intermediate degradation.
Applied microbiology and biotechnology·2026
Integrative Approaches in Protein Structure/Function Analysis, Design, and Engineering.
Advances in biochemical engineering/biotechnology·2026
Structural basis for substrate specificity switching revealed by the FlhA(A489E) suppressor mutation.
Biophysics and physicobiology·2026
Production Optimization, Partial Purification, and Biochemical Characterization of an Extracellular Lipase from Proteus mirabilis SAB2.
International journal of microbiology·2026
Kininase I drives angiotensin II-induced hypertension through activation of the bradykinin B1 receptor.
British journal of pharmacology·2026